– Anticanceragent 242 (7) exhibits anticancer activity across various cancer cell types. For instance, in ovarian adenocarcinoma cells A2780, it shows an IC50 of 0.24 μM and in A2780cis cells, an IC50 of 0.45 μM. Additionally, it demonstrates efficacy in CCD18Co non-malignant human fibroblasts with an IC50 of 0.59 μM, lung adenocarcinoma A549 cells with an IC50 of 0.32 μM, colorectal adenocarcinoma HT29 cells with an IC50 of 0.26 μM, and in breast adenocarcinoma MCF7 cells with an IC50 of 0.55 μM.